Danaher Corp
Research Danaher Corp (DHR) on Bullrun: valuation model: 9.5% overvalued, market cap USD 151.81B, P/E 38.3, dividend yield 0.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDHR
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Valuation signal9.5% overvalued
- Market capUSD 151.81B
- P/E38.3
- Dividend yield0.7%
- Financial periodQ2 2026
- RevenueUSD 6.27B
- Net incomeUSD 870.00M
- Free cash flowUSD 1.27B
- Gross margin57.6%
Valuation Snapshot
Bullrun's latest valuation model marks Danaher Corp as 9.5% overvalued; latest market cap is USD 151.81B; P/E is 38.3; dividend yield is 0.7%.
Peer valuation comparison
Latest P/E is 38.35x versus a Healthcare sector median of 24.46x (56.8% above).
Latest dividend yield is 0.67% versus a Healthcare sector median of 2.11% (68.2% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 24.57B | USD 3.61B | USD 5.26B | 59.1% | 5.05 | USD 4.62B | USD 18.42B | USD 52.53B |
| FY2024 | USD 23.88B | USD 3.90B | USD 5.30B | 59.5% | 5.29 | USD 2.08B | USD 16.01B | USD 49.54B |
| FY2023 | USD 23.89B | USD 4.76B | USD 5.78B | 58.7% | 6.38 | USD 5.86B | USD 18.40B | USD 53.49B |
| FY2022 | USD 26.64B | USD 7.21B | USD 7.40B | 60.8% | 9.66 | USD 6.00B | USD 19.68B | USD 50.08B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 151.81B | 38.3 | 0.7% | 1.44 |
| 2025 | 2025-12-31 | USD 161.82B | 45.3 | 0.6% | 1.28 |
| 2024 | 2024-12-31 | USD 165.07B | 43.4 | 0.5% | 1.08 |
| 2023 | 2023-12-29 | USD 170.94B | 29.3 | 0.4% | 0.99 |
| 2022 | 2022-12-30 | USD 171.29B | 26.0 | 0.4% | 0.88 |
| 2021 | 2021-12-31 | USD 208.55B | 33.9 | 0.3% | 0.76 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.44 USD, yield 0.7%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1.28 USD |
| FY2024 | 1.08 USD |
| FY2023 | 0.99 USD |
| FY2022 | 0.88 USD |
About Danaher Corp
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Danaher Corp overvalued or undervalued?
Bullrun's valuation model currently marks Danaher Corp as 9.5% overvalued.
What is Danaher Corp's market cap?
Danaher Corp's market capitalization is USD 151.81B.
What is Danaher Corp's P/E ratio?
Danaher Corp's price-to-earnings (P/E) ratio is 38.3.
Does Danaher Corp pay a dividend?
Danaher Corp has a dividend yield of 0.7%.
What does Danaher Corp do?
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments.